Patent details

Basic Information

Publication number:

EP3753554

PCT Application Number:

KR2019000219

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP197543580

PCT Publication Number:

WO2019160243

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

EXTENDED-RELEASE PHARMACEUTICAL COMPOSITION CONTAINING LACOSAMIDE

French Title of Invention:

COMPOSITION PHARMACEUTIQUE À LIBÉRATION PROLONGÉE CONTENANT DU LACOSAMIDE

German Title of Invention:

LACOSAMID ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT VERZÖGERTER FREISETZUNG

SPC Number:

Dates

Filing date:

07/01/2019

Grant date:

22/03/2023

EP Publication Date:

23/12/2020

PCT Publication Date:

22/08/2019

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/03/2023

EP B1 Publication Date:

22/03/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

07/01/2024

Expiration date:

07/01/2039

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/03/2023

 

 

Name:

Whan In Pharmaceutical Company

Address:

11, Beobwon-ro 6-gil Songpa-gu, Seoul 05855, Korea (Republic) (KR)

Inventor

1

Name:

PARK, Jin Hyeong

Address:

Korea (Republic) (KR)

2

Name:

LEE, Na Kyeom

Address:

Korea (Republic) (KR)

3

Name:

MIN, Mi Hong

Address:

Korea (Republic) (KR)

Priority

Priority Number:

20180018584

Priority Date:

14/02/2018

Priority Country:

Korea (Republic) (KR)

Classification

IPC classification:

A61K 9/24; A61K 9/20; A61K 9/28; A61K 31/165;

Publication

European Patent Bulletin

Issue number:

202312

Publication date:

22/03/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages